Table 3 Trial outcomes and costs
Outcomes | Intervention (n = 455) | Usual care (n = 451) | Difference | |
Mean (se) | Mean (se) | Mean (95% CI) | ||
Quit rates at 24-week follow-up | ||||
Point prevalence | 23.1% (2.0%) | 21.7% (1.9%) | 1.3% (−4.1 to 6.8%) | |
EQ-5D utility scores | ||||
Baseline | 0.792 (0.01) | 0.800 (0.01) | −0.008 (−0.035 to 0.019) | |
24-week follow-up | 0.800 (0.01) | 0.803 (0.01) | −0.002 (−0.029 to 0.025) | |
Leisure-time physical activity (MET mins/week) | ||||
Change from baseline | 526 (69) | 307 (66) | 219 (53 to 386) | |
Costs | Quantity | Unit cost | 2012 NZ$ | Source |
Intervention, programme costs | ||||
a) training for PSPs provided by investigators (trainer hours) | 9 | 125 | 1,125 | Trial |
b) PSP salary incl. 25% overhead | 2 | 75,000 | 150,000 | Trial |
Intervention, cost per participant (n = 455) | ||||
a) PSP training costs per Fit2Quit participant | 2.47 | Trial | ||
b) PSP salary | 329.67 | Trial | ||
c) GP visit for Green Prescription | 65.00 | Estimate | ||
d) pedometer | 1 | 30.44 | 30.44 | Trial |
e) Quitline | 1 | 195.33 | 195.33 | [32] |
Total | 622.91 | |||
Usual care, Quitline cost per participant (n = 451) | Total | 195.33 | [32] | |